Beyond Glycemia: Pharmacology-Driven Ketogenesis and Euglycemic DKA with SGLT2 Inhibitors—A Practical Review for Acute Care
Open Access
- 10 March 2026
- journal article
- review article
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 16 (3) , 156
Abstract
Sodium–glucose cotransporter-2 inhibitors (SGLT2i) are widely prescribed for type 2 diabetes, heart failure, and chronic kidney disease. A rare but dangerous adverse event is SGLT2i-associated diabetic ketoacidosis, often euglycaemic (euDKA), and therefore easy to miss. This narrative review summarizes mechanisms, triggers (fasting, dehydration, infection, perioperative stress), and ketone-centred pathways for diagnosis, treatment, and prevention in acute-care settings. Management priorities are volume resuscitation, blood β-hydroxybutyrate and acid–base testing, insulin infusion with dextrose to suppress ketogenesis, and electrolyte replacement. Prevention relies on “sick-day” rules, perioperative drug withholding, and a low threshold for ketone testing in any patient with high-anion-gap acidosis, despite normal or mildly elevated glucose.Keywords
This publication has 34 references indexed in Scilit:
- Preoperative SGLT2 Inhibitor Use and Postoperative Diabetic KetoacidosisJAMA Surgery, 2025
- Updates on perioperative cessation of SGLT2 inhibitorsBritish Journal of Anaesthesia, 2025
- Euglycemic diabetic ketoacidosis: Etiologies, evaluation, and managementThe American Journal of Emergency Medicine, 2021
- Perioperative diabetic ketoacidosis associated with sodium-glucose co-transporter-2 inhibitors: a systematic reviewBritish Journal of Anaesthesia, 2019
- Euglycemic diabetic ketoacidosisEuropean Journal of Internal Medicine, 2019
- Ketoacidosis associated with SGLT2 inhibitor treatment: Analysis of FAERS dataDiabetes/Metabolism Research and Reviews, 2017
- Management of Hyperglycemic CrisesMedical Clinics of North America, 2017
- SGLT2 Inhibitor–associated Diabetic Ketoacidosis: Clinical Review and Recommendations for Prevention and DiagnosisClinical Therapeutics, 2016
- Diabetic emergencies — ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemiaNature Reviews Endocrinology, 2016
- Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretionNature Medicine, 2015